Information on new prescription diet pills
Tesofensine is a weight loss drug still being put through testing phases. Its developers are NeuroSearch based out of Denmark. It started its testing and development later than those of Qnexa, Lorcaserin and Contrave. As a result it still at the time of this writing has not entered into phase three testing to our knowledge. Phase three testing is very in-depth usually lasting about one year's time and with possibly thousands of people involved. If all goes well, it would still be at least one to two years before it was submitted to the FDA. Tesofensine was first being developed to treat Parkinson's and Alzheimer's disease but was resulting in poor results for their treatment. But during the testing it was found that Tesofensine was really producing great results in weight loss. This is what caused the discovery and development as Tesofensine as a weight loss drug. Test results out have Tesofensine beating out the results of Sibutramine (A current anti-obesity drug) by double the weight loss.
A benefit shared with that of Lorcaserin is that a study showed that Tesofensine has a very low change of abuse or be taken for recreational purposes. If this stat holds true over any phase three testing and continues to work twice as well as Sibutramine it could be one of the biggest players in the weight loss drug field. Over a 6 month testing phase patients where found to lose an average of 10.6% of there body mass. Those who merely took half of this still lost an average of 9.6% of their weight. Side effects reported have been mid to moderate levels of insomnia, dry mouth, constipation and some gastrointestinal tract issues but nothing too serious and not found with all takers. So far there is not a lot to report on Tesofensine as it still needs further testing to give its argument strength. But this one could hold a lot of potential.